Glutamate and Opioid Mechanisms of Antidepressant Response to Ketamine

NCT04977674 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Depressive Disorder, Treatment-Resistant

Interventions

DRUG: Naltrexone
DRUG: Placebo
DRUG: Ketamine

Sponsor

King's College London